TransMedics stock rating upgraded to Buy at Needham on transplant growth
PositiveFinancial Markets

TransMedics has received an upgraded stock rating to 'Buy' from Needham, reflecting optimism about the company's growth in the transplant sector. This upgrade is significant as it indicates confidence in TransMedics' potential to expand its market presence and improve patient outcomes, which could lead to increased investor interest and a positive impact on the company's stock performance.
— Curated by the World Pulse Now AI Editorial System










